Advertisement
Research Article

Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma

  • Phuong L. Mai equal contributor mail,

    equal contributor Contributed equally to this work with: Phuong L. Mai, Nilanjan Chatterjee

    maip@mail.nih.gov

    Affiliation: Clinical Genetic Branch, National Cancer Institute, Rockville, Maryland, United States of America

    X
  • Nilanjan Chatterjee equal contributor,

    equal contributor Contributed equally to this work with: Phuong L. Mai, Nilanjan Chatterjee

    Affiliation: Biostatistics Branch, National Cancer Institute, Rockville, Maryland, United States of America

    X
  • Patricia Hartge,

    Affiliation: Office of Director of the Biostatistics and Epidemiology Program, National Cancer Institute, Rockville, Maryland, United States of America

    X
  • Margaret Tucker,

    Affiliation: Genetic Epidemiology Branch of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

    X
  • Lawrence Brody,

    Affiliation: National Human Genome Research Institute, Rockville, Maryland, United States of America

    X
  • Jeffery P. Struewing,

    Affiliation: National Human Genome Research Institute, Rockville, Maryland, United States of America

    X
  • Sholom Wacholder

    Affiliation: Biostatistics Branch, National Cancer Institute, Rockville, Maryland, United States of America

    X
  • Published: March 11, 2009
  • DOI: 10.1371/journal.pone.0004812

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.